Work

Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant

Year: 2015

Type: article

Source: Clinical Immunology

DOI: 10.1016/j.clim.2015.06.006

Authors: Bala Vamsi K. Karuturi, Shailendra B. Tallapaka, Joy A. Phillips, Sam D. Sanderson, Joseph A. Vetro

Institutions: University of Nebraska Medical Center, San Diego State University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Center for Research Resources

Awards: Nebraska Center for Nanomedicine, Pulmonary delivery of a hybrid therapeutic to halt respiratory viral infection, G3488383117, Nebraska Center for Nanomedicine, Response-Selective C5a Agonist for the Treatment of Asthma

OpenAlex ID: W847812966

FWCI: 0.492

Cites: 59

Cited by: 11

Related to: 10